Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
At age 50, you can make catch-up contributions to enhance your retirement savings. Understand how to take full advantage of this opportunity.
6,963 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Delta Air Lines posted a notable weekly gain, with delta stock 9.38% this week, even as retail social chatter turned ...
When Nvidia shares stumble, savvy investors look for high-potential AI names that can keep delivering. Here are two s...
When every dollar counts, retirees stretching $10,000 savings need a plan that blends frugality with opportunity. Thi...
After years of watching this stock trade at lofty valuations, a broad market sell-off finally creates an entry point....
A headline like OpenAI Just Became Broadcom's New Chip Customer signals a dramatic turn in AI hardware. This article ...
Two popular U.S. tech ETFs—VGT and FTEC—often attract the same investor despite different price tags on cost and liqu...
The Magnificent Seven have driven market gains, but AI spending is fueling new ideas. Could this stock better bargain...
As AI moves from model training to real-time inference, one chipmaker looms large for investors. This story explains ...
MP Materials scored a powerful April rally, but the move wasn’t sparked by a single headline. This article digs into ...
Two retail powerhouses deliver contrasting plays for 2026: Amazon bets big on AI and cloud infrastructure, while Walm...
Rivian shares have faced a meaningful pullback, leaving many investors wondering if the rivian stock dip? creates a b...